Israel Englander Dexcom Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Dexcom Inc stock. As of the latest transaction made, Millennium Management LLC holds 390,800 shares of DXCM stock, worth $31.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

390,800

Previous 36,300 976.58%

Holding current value

$31.4 Million

Previous $4.12 Million 536.48%

% of portfolio

0.01%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $17.7 Million - $32.2 Million	277,152 Added 429.75%	341,643 $22.9 Million
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $65.1 Million - $82.9 Million	-590,105 Reduced 90.15%	64,491 $7.31 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $42.6 Million - $52.2 Million	-372,563 Reduced 36.27%	654,596 $90.8 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $66.2 Million - $109 Million	-876,306 Reduced 46.04%	1,027,159 $127 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $86.8 Million - $101 Million	-771,329 Reduced 28.84%	1,903,465 $245 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $126 Million - $149 Million	-1,215,855 Reduced 31.25%	2,674,794 $311 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $226 Million - $326 Million	2,658,077 Added 215.65%	3,890,649 $441 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $20.1 Million - $24.8 Million	263,739 Added 27.22%	1,232,572 $99.3 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $50.5 Million - $98.7 Million	742,391 Added 327.85%	968,833 $72.2 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $4.95 Million - $6.85 Million	-52,606 Reduced 18.85%	226,442 $116 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $34.3 Million - $42.9 Million	263,737 Added 1722.53%	279,048 $150 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $1.28 Million - $1.72 Million	-12,019 Reduced 43.98%	15,311 $8.37 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $1.02 Million - $1.26 Million	12,051 Added 78.87%	27,330 $9.82 Million
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $7.51 Million - $10.1 Million	-96,294 Reduced 86.31%	15,279 $5.65 Million
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $8.22 Million - $9.72 Million	-86,078 Reduced 43.55%	111,573 $46 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $6.24 Million - $10.5 Million	99,509 Added 101.39%	197,651 $80.1 Million
Q1 2020 May 14, 2020	SELL	$47.79 - $75.63 $11.8 Million - $18.6 Million	-246,385 Reduced 71.51%	98,142 $26.4 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $10.6 Million - $16.6 Million	289,198 Added 522.69%	344,527 $75.4 Million
Q3 2019 Nov 14, 2019	SELL	$35.53 - $43.8 $14.6 Million - $18 Million	-409,938 Reduced 88.11%	55,329 $8.26 Million
Q2 2019 Aug 15, 2019	BUY	$27.84 - $38.92 $12.5 Million - $17.5 Million	449,520 Added 2854.64%	465,267 $69.7 Million
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $18.1 Million - $25.3 Million	-649,379 Reduced 97.63%	15,747 $902,000
Q1 2019 May 14, 2019	SELL	$28.07 - $38.18 $414,257 - $563,460	-14,758 Reduced 2.17%	665,126 $79.2 Million
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $17.4 Million - $24.1 Million	-644,136 Reduced 48.65%	679,884 $81.5 Million
Q3 2018 Nov 14, 2018	SELL	$23.35 - $36.72 $7.07 Million - $11.1 Million	-302,897 Reduced 18.62%	1,324,020 $189 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $12.2 Million - $17.6 Million	697,438 Added 75.04%	1,626,917 $155 Million
Q1 2018 May 15, 2018	BUY	$13.06 - $18.54 $6.84 Million - $9.7 Million	523,438 Added 128.91%	929,479 $68.9 Million
Q4 2017 Feb 14, 2018	BUY	$11.12 - $15.38 $4.52 Million - $6.24 Million	406,041	406,041 $23.3 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account